Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre van Damme

Showing results (21-30 of 365) with videos related to

Pageof 37
Sort By:
Vaccine|February 3, 2007
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006)Froukje Oosterhuis-Kafeja, Philippe Beutels, Pierre Van Damme
Vaccine|November 27, 2007
Prevention and control of viral hepatitis through adolescent health programmes in EuropeDavid FitzSimons, Alex Vorsters, Karel Hoppenbrouwers, et al.
Vaccine|November 21, 2009
Hepatitis A and E: update on prevention and epidemiologyDavid FitzSimons, Greet Hendrickx, Alex Vorsters, et al.
Acta Medica Portuguesa|May 13, 2014
Do vaccines save lives? Yes they do!Tinne Lernout, Heidi Theeten, Elke Leuridan, et al.
Vaccine|November 13, 2012
Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011David FitzSimons, Greet Hendrickx, Alex Vorsters, et al.
Vaccine|March 5, 2003
Combined hepatitis B vaccinesDavid FitzSimons, Guido François, Nedret Emiroğlu, et al.
Journal of Medical Virology|September 15, 2011
Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 yearsKoen Van Herck, Jeanne-Marie Jacquet, Pierre Van Damme
Human Vaccines & Immunotherapeutics|February 18, 2022
Evolving measles status and immunization policy development in six European countriesIvo Vojtek, Heidi Larson, Stanley Plotkin, et al.
Vaccine|October 28, 2017
Recruitment barriers for prophylactic vaccine trials: A study in BelgiumLauriane Harrington, Pierre Van Damme, Corinne Vandermeulen, et al.
Expert Review of Vaccines|August 12, 2003
Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for useFrancis André, Pierre Van Damme, Assad Safary, et al.
Pageof 37

Showing results (21-30 of 365) with videos related to

Sort By:
Pageof 37
Vaccine|February 3, 2007
Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006)Froukje Oosterhuis-Kafeja, Philippe Beutels, Pierre Van Damme
Vaccine|November 27, 2007
Prevention and control of viral hepatitis through adolescent health programmes in EuropeDavid FitzSimons, Alex Vorsters, Karel Hoppenbrouwers, et al.
Vaccine|November 21, 2009
Hepatitis A and E: update on prevention and epidemiologyDavid FitzSimons, Greet Hendrickx, Alex Vorsters, et al.
Acta Medica Portuguesa|May 13, 2014
Do vaccines save lives? Yes they do!Tinne Lernout, Heidi Theeten, Elke Leuridan, et al.
Vaccine|November 13, 2012
Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011David FitzSimons, Greet Hendrickx, Alex Vorsters, et al.
Vaccine|March 5, 2003
Combined hepatitis B vaccinesDavid FitzSimons, Guido François, Nedret Emiroğlu, et al.
Journal of Medical Virology|September 15, 2011
Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 yearsKoen Van Herck, Jeanne-Marie Jacquet, Pierre Van Damme
Human Vaccines & Immunotherapeutics|February 18, 2022
Evolving measles status and immunization policy development in six European countriesIvo Vojtek, Heidi Larson, Stanley Plotkin, et al.
Vaccine|October 28, 2017
Recruitment barriers for prophylactic vaccine trials: A study in BelgiumLauriane Harrington, Pierre Van Damme, Corinne Vandermeulen, et al.
Expert Review of Vaccines|August 12, 2003
Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for useFrancis André, Pierre Van Damme, Assad Safary, et al.
Pageof 37